Agios Pharmaceuticals Inc (NASDAQ:AGIO) - Share price - Overview

Stock Report

Agios Pharmaceuticals Inc AGIO

Last Price
$54.09

Day Change
4.26|8.55%

As of 17/02/2017
16:00:00 EST | USD
Minimum 15 Minutes Delay.

Last Close49.83
Day Range49.09 - 54.23
Mkt Cap2.28Bil
52-Wk Range34.31 - 67.74
Yield %-
ISINUS00847X1046
Volume1,137,186
P/E-11.25
P/S38.46
P/CF34.70

Share Price

Financials
201320142015
More ...
Income Statement
Revenue25.5565.3659.12
Operating Income-38.88-54.13-118.70
Net Income-39.41-53.50-117.73
Basic EPS-2.83-1.59-3.15
Avg. Diluted Shares Outstanding153437
Balance Sheet
Current Assets169.75359.55337.33
Non Current Assets31.46132.3682.74
Total Assets201.21491.90420.07
Current Liabilities36.9361.0952.89
Total Liabilities69.7267.5474.95
Total Equity131.48424.37345.12
Cash Flow
Operating Cash Flow-56.40-59.35-76.95
Capital Expenditure-1.29-2.22-20.16
Free Cash Flow-57.69-61.57-97.11

In millions, except "Basic EPS". Currency is USD.

Company Profile

Agios Pharmaceuticals Inc is engaged in the development of medicines to treat cancer metabolism and inborn errors of metabolism, which are a subset of orphan genetic metabolic diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

287
Key Stats
More ...
Price/Earning TTM-10.36
Price/Book5.24
Price/Sales TTM35.43
Rev Growth (3 year avg)33.04
EPS Growth (3 year avg)-
Operating Margin % TTM-200.78
Net Margin % TTM-199.14
ROE TTM-30.60
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.